Benedetti, Elisa
Pučić-Baković, Maja
Keser, Toma http://orcid.org/0000-0003-2759-3742
Wahl, Annika
Hassinen, Antti
Yang, Jeong-Yeh
Liu, Lin
Trbojević-Akmačić, Irena
Razdorov, Genadij http://orcid.org/0000-0001-6370-8434
Štambuk, Jerko
Klarić, Lucija
Ugrina, Ivo http://orcid.org/0000-0002-9882-2250
Selman, Maurice H. J.
Wuhrer, Manfred http://orcid.org/0000-0002-0814-4995
Rudan, Igor http://orcid.org/0000-0001-6993-6884
Polasek, Ozren
Hayward, Caroline http://orcid.org/0000-0002-9405-9550
Grallert, Harald
Strauch, Konstantin
Peters, Annette
Meitinger, Thomas
Gieger, Christian
Vilaj, Marija
Boons, Geert-Jan
Moremen, Kelley W.
Ovchinnikova, Tatiana
Bovin, Nicolai
Kellokumpu, Sakari
Theis, Fabian J. http://orcid.org/0000-0002-2419-1943
Lauc, Gordan
Krumsiek, Jan http://orcid.org/0000-0003-4734-3791
Article History
Received: 25 September 2016
Accepted: 25 September 2017
First Online: 14 November 2017
Change Date: 13 February 2018
Change Type: Correction
Change Details: Correction to: Nature Communications (2017) 8:1231. doi:10.1038/s41467-017-01525-0
Competing interests
: G.L. declares that he is a founder and owner of Genos, a private research organization that specializes in high-throughput glycomics and has several patents in the field. M.P.-B., I.T.-A., G.R., J.S., L.K. and M.V. are employees of Genos. The remaining authors declare no competing financial interests.